Loading...
Please wait, while we are loading the content...
Similar Documents
Vena Cava Filters.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Wyble, Charles W. |
| Copyright Year | 2016 |
| Abstract | Considerable progress has been made in the last decade in understanding the natural history of “treated” venous thromboembolism (VTE). VTE occurs at a rate of 1/1000 in the general population1 and significantly increases with age, especially after age 60, with rates as high as 1/100.2 Duplex ultrasonography has largely replaced venography as the diagnostic test of choice for deep venous thrombosis (DVT),3 and spiral CT pulmonary angiography is rapidly replacing ventilation/perfusion lung scans as the diagnostic test of choice for pulmonary embolism (PE).4 Multiple agents are now available for the initial treatment of VTE including unfractionated heparin, low-molecular-weight heparin, and fondaparinux,5 and although the vitamin K antagonists remain the sole oral agents for the long-term treatment of VTE, new oral alternatives are on the horizon.6 As the result of large randomized controlled trials the secondary prevention of recurrent VTE has improved, with the duration of therapy now based on an understanding of the initial inciting event and the presence of ongoing risk factors.7 Patients with idiopathic DVT or persistent risk factors require anticoagulant therapy for a minimum of 6 months, and more likely, 12 months, with a cumulative risk of recurrence as high as 30% at 8 years.8 For patients with cancer and VTE, it has been shown that therapy with low-molecular-weight heparin for the first 3 to 6 months results in better outcomes than the outcomes of patients transitioned to warfarin early in the course of therapy.9 Unfortunately, the application of vena cava interruption has not undergone the same robust scrutiny as have other therapeutic interventions, and consequently our knowledge of when and how to use inferior vena cava (IVC) interruption is limited. That is, until now. |
| Starting Page | 9 |
| Ending Page | 9 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://circ.ahajournals.org/content/circulationaha/112/3/298.full.pdf?download=true |
| Alternate Webpage(s) | https://www.bostonscientific.com/content/dam/bostonscientific/pi/portfolio-group/vena-cava-filters/greenfield/resources/Greenfield_Sell_Sheet_PI-25210-AA.pdf |
| PubMed reference number | 29813214v1 |
| Journal | Journal of the Medical Association of Georgia |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Anticoagulants Deep Vein Thrombosis Diagnostic tests Heparin, Low-Molecular-Weight Idiopathic Pulmonary Fibrosis Inferior vena cava structure Natural History Neoplasms Patients Pulmonary Embolism Respiration Secondary Prevention Structure of vein of trunk Superior Vena Cava Syndrome Vena Cava Filters Venography - procedure Venous Thromboembolism Venous Thrombosis Vitamin K Warfarin X-Ray Computed Tomography angiogram heparin |
| Content Type | Text |
| Resource Type | Article |
